You are now leaving helsinn.com

Please click 'Continue to external site' if you want to continue.

Our Management Team

Our Management Team brings together wide-ranging expertise from across the whole of cancer care and rare diseases through product development of therapies through to commercialization products. We’re focused on pushing further to deliver more life-changing treatments for people with cancer today and in the future.

Helsinn’s Senior Executive Committee Team

Riccardo Braglia

Group Vice Chairman & CEO, Board Member & US Chairman

Giorgio Calderari

Group General Manager & Chief Operating Officer & U.S. Board Member

Konrad Wilson

Group Chief Financial Officer

Andrea Meoli

Group Chief Commercial Officer

Sergio Cantoreggi

Group Chief Scientific Officer and Global Head of R&D

Matteo Missaglia

Group General Counsel and Chief Legal Officer

Helsinn's Management Team

Waldo Mossi

Local General Manager, Helsinn Advanced Synthesis SA, Switzerland

Roberta Cannella

Group Head of Manufacturing and CMC

Paul Rittman

Local CEO, Helsinn Therapeutics (U.S.), Inc., USA

Cristina Marenzi

Group Head of Human Resources

Enrico Magnani

Local General Manager, Helsinn Pharmaceuticals (Beijing) Co., Ltd., P.R.C.

Matteo Santi

Group Compliance Officer and Group Head of Compliance and Quality

Deirdre Hurley

Local General Manager, Helsinn Birex Pharmaceuticals Ltd., Ireland

Roberto Lazari

Group Head of Information and Communications Technology

Georg Büchner

Group Head of Business Development